These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 15824048

  • 1. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity.
    Suputtitada A, Suwanwela NC.
    Disabil Rehabil; 2005 Feb 18; 27(4):176-84. PubMed ID: 15824048
    [Abstract] [Full Text] [Related]

  • 2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 Feb 18; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J, Bogucki A, Reclawowicz D.
    Neurol Sci; 2005 Apr 18; 26(1):32-9. PubMed ID: 15877185
    [Abstract] [Full Text] [Related]

  • 4. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.
    Arch Phys Med Rehabil; 2008 May 18; 89(5):799-806. PubMed ID: 18452724
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J, Landrault E, Jacquin-Courtois S, Mertens P, Rode G, Boisson D.
    Ann Readapt Med Phys; 2004 Oct 18; 47(8):555-62. PubMed ID: 15465160
    [Abstract] [Full Text] [Related]

  • 6. [Botulinum toxin type A treatment of upper limb spasticity].
    Wissel M, Wissel J.
    Wien Klin Wochenschr; 2001 Oct 18; 113 Suppl 4():16-9. PubMed ID: 15506047
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.
    Bakheit AM, Thilmann AF, Ward AB, Poewe W, Wissel J, Muller J, Benecke R, Collin C, Muller F, Ward CD, Neumann C.
    Stroke; 2000 Oct 18; 31(10):2402-6. PubMed ID: 11022071
    [Abstract] [Full Text] [Related]

  • 8. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F, Sandrini G, Moglia A, Nappi G, Pacchetti C.
    Neurol Sci; 2005 Apr 18; 26(1):26-31. PubMed ID: 15877184
    [Abstract] [Full Text] [Related]

  • 9. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
    Sätilä H, Kotamäki A, Koivikko M, Autti-Rämö I.
    Pediatr Rehabil; 2006 Apr 18; 9(3):247-58. PubMed ID: 17050402
    [Abstract] [Full Text] [Related]

  • 10. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
    Yablon SA, Brashear A, Gordon MF, Elovic EP, Turkel CC, Daggett S, Liu J, Brin MF.
    Clin Ther; 2007 Apr 18; 29(4):683-90. PubMed ID: 17617291
    [Abstract] [Full Text] [Related]

  • 11. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
    Hu GC, Chuang YC, Liu JP, Chien KL, Chen YM, Chen YF.
    Clin Rehabil; 2009 Jan 18; 23(1):64-71. PubMed ID: 19114438
    [Abstract] [Full Text] [Related]

  • 12. Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.
    Truong D, Brodsky M, Lew M, Brashear A, Jankovic J, Molho E, Orlova O, Timerbaeva S, Global Dysport Cervical Dystonia Study Group.
    Parkinsonism Relat Disord; 2010 Jun 18; 16(5):316-23. PubMed ID: 20359934
    [Abstract] [Full Text] [Related]

  • 13. Botulinum treatment for post-stroke spasticity: low dose regime.
    Viriyavejakul A, Vachalathiti R, Poungvarin N.
    J Med Assoc Thai; 1998 Jun 18; 81(6):413-22. PubMed ID: 9676073
    [Abstract] [Full Text] [Related]

  • 14. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis.
    Giovannelli M, Borriello G, Castri P, Prosperini L, Pozzilli C.
    Clin Rehabil; 2007 Apr 18; 21(4):331-7. PubMed ID: 17613573
    [Abstract] [Full Text] [Related]

  • 15. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
    Ashford S, Turner-Stokes L.
    Disabil Rehabil; 2009 Apr 18; 31(3):220-6. PubMed ID: 18608366
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H, Heinze A, Reichel G, Hefter H, Benecke R, Dysport myofascial pain study group.
    Pain; 2006 Nov 18; 125(1-2):82-8. PubMed ID: 16750294
    [Abstract] [Full Text] [Related]

  • 17. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity.
    Kong KH, Neo JJ, Chua KS.
    Clin Rehabil; 2007 Jan 18; 21(1):28-35. PubMed ID: 17213238
    [Abstract] [Full Text] [Related]

  • 18. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW, Tan HJ, Norlinah MI, Nafisah WY, Ramesh S, Hamidon BB, Raymond AA.
    Med J Malaysia; 2007 Oct 18; 62(4):319-22. PubMed ID: 18551937
    [Abstract] [Full Text] [Related]

  • 19. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE, Racette BA.
    Pediatr Neurol; 2008 Oct 18; 39(4):253-8. PubMed ID: 18805363
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
    Truong D, Duane DD, Jankovic J, Singer C, Seeberger LC, Comella CL, Lew MF, Rodnitzky RL, Danisi FO, Sutton JP, Charles PD, Hauser RA, Sheean GL.
    Mov Disord; 2005 Jul 18; 20(7):783-91. PubMed ID: 15736159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.